All News

ACR Clean (Keep)

ACR Applauds E/M Coding Changes, Telehealth Expansion in CY 2021 Physician Fee Schedule Proposed Rule

d

The American College of Rheumatology (ACR) today applauded the Centers for Medicare and Medicaid Services (CMS) for taking steps to appropriately value cognitive care and expand telehealth access in its CY 2021 Physician Fee Schedule (PFS) Proposed Rule.

Read Article
podcastLogo-01%20RESIZED.jpg

RheumNow Podcast – Why Do We Love Rheumatology Fellows? (8.7.20)

d Jack Cush, MD

Dr. Jack Cush reviews why we all love our rheumatology fellows and our best advice for them stemming from these articles.

Read Article
Xeljanz4.jpg

Thromboembolic Risk with Tofacitinib in RA, PsA and UC

d Jack Cush, MD

An analysis of the tofacitinib (Xeljanz) drug development program in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ulcerative colitis suggests a low level risk for venous (VTE) and arterial thromboembolism (ATE).  

Read Article
ANCA_5.jpg

Long-Term Rituximab in ANCA-Associated Vasculitis

d Jack Cush, MD

The Annals of Internal Medicine reports that biannual rituximab infusions over 18 months was effective at maintaining remission in patients with antineutrophil cytoplasmic antibody–associated vasculitis (AAV).

Read Article
ild.jpg

Methotrexate Not Associated with Interstitial Lung Disease

d Jack Cush, MD

A case-controlled study shows that methotrexate (MTX) use in rheumatoid arthritis (RA) is not associated with interstitial lung disease (ILD) according to a report in the European Respiratory Journal.

Read Article
Correlation study of MRI and OA features finds meniscal extrusion, full thickness cartilage loss and osteophytes were associated with clinical knee pain. Study of 294 OA knee patients from the Osteoarthritis Initiative (at least 4 MRI over 6 years) https://t.co/t95eGbX9iN

Links:

Dr. John Cush RheumNow ( View Tweet)

Mortality study of 18,943 patients with PMR and 87,801 matched controls from the Clinical Practice Datalink with 8 yrs of followup finds NO increase in mortality in PMR patients adjusted MRR 1.00 [95% CI 0.97, 1.03]). https://t.co/moZwiuhOxC

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow Podcast - Why we Love Rheumatology Fellows (8.7.20) Watch it here>> https://t.co/ftrycqoWRR or Listen to the podcast on iTunes or on SoundCloud>> https://t.co/gi5hO0HaIl

Links:

Dr. John Cush RheumNow ( View Tweet)

Dr. D. Minna @UTSWNews rheum grand rounds: review of OA: 1. Exercise may increase cartilage volume 2. Osteophytes are an adaptation to mechanical stimuli rather than a degen. process (no correl w/cartilage volume) 3. Hallmark of OA is abn. matrix turnover @RheumNow

k dao KDAO2011 ( View Tweet)

NIH taps Dr. Lindsey Criswell as the New Director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases. She was the vice chancellor of research and a professor of rheumatology at UCSF. She begins in early 2021. Congrats!! https://t.co/H1wpYHOOWg

Links:

Dr. John Cush RheumNow ( View Tweet)

BMS has announced deucravacitinib: the generic name for its Tyk2 inhibitor (BMS-986165) - 15 long makes it a new rheum labeling record. It's being studied in Psoriatic arthritis, psoriasis, lupus and inflammatory bowel disease. https://t.co/E2x2lelktO

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow Podcast - Why we Love Rheumatology Fellows (8.7.20) Watch it here>> https://t.co/ftrycqoWRR or Listen to the podcast on iTunes or on SoundCloud>> https://t.co/gi5hO0HaIl

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow Podcast - Why We Love Rheumatology Fellows (8-7-20) Dr. Jack Cush reviews why we all love our rheumatology fellows and our best advice for them stemming from these articles" https://t.co/7y9ap0AkdD https://t.co/LDFLQEIN4r

Links:

Dr. John Cush RheumNow ( View Tweet)
Hong Kong study Myositis-specific autoantibodies in 201 pts with idiopathic inflammatory myopathies (IIM) shows MDA-5 (14%), TIFF-1γ (14%), Jo-(12.4%). MDA5 seen w/ DM, digital ulcers, amyopathy, ILD. TIF1γ was associ w/ refractory rash and cancer https://t.co/3E365F5SON

Links:

Dr. John Cush RheumNow ( View Tweet)

Sleep is a problem in Lupus! Metanalysis of 18 studies (n=1086) shows #SLE has lower sleep quality - The main problems being daytime dysfunction (WMD 0.64), subjective sleep quality (WMD 0.62) & habitual sleep efficiency (WMD  0.54) https://t.co/odSdm4E9iW

Links:

Dr. John Cush RheumNow ( View Tweet)

RA is associated with a 24‐35% lower risk of type 2 diabetes. Claims data comparison of 449,327 RA, general non‐RA, hypertension, OA, or PsA patients finds a lower risk of T2DM in RA (7/1000PY) and highest w/ HTN (12.3/1000PY) https://t.co/uZn5qaImO9

Links:

Dr. John Cush RheumNow ( View Tweet)

Study of 662 temporal artery Bx shows that when diagnosing #GCA, the TAB length should be at least 5 mm and should analyze at least 3 further sections at deeper levels for maximal yield. https://t.co/6zM9hBUsXy

Links:

Dr. John Cush RheumNow ( View Tweet)

A UK general practice dataset compared mortality outcomes in 18,943 #PMR patients vs 87,801 controls. With mean F/U of 8 yrs, they found PMR was not associated with increased mortality (adjusted MRR 1.00 [95% CI 0.97, 1.03]) vs matched controls. https://t.co/moZwiuhOxC

Links:

Dr. John Cush RheumNow ( View Tweet)

Analysis of PPI use from the Nurses Health Study shows regular PPI use was associated with increased risk of RA in women, higher with a longer duration of PPI use. With 1.7 million PY F/U, Regular PPI users had a 44% higher RA risk (adjHR 1.44; 1.10–1.89) https://t.co/pmBf88zGKH

Links:

Dr. John Cush RheumNow ( View Tweet)

Full read clinical practice guideline on obesity management from the Canadian Medical Assn Journal. https://t.co/YdbjtnBcST

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×